title: Sulindac plus erlotinib for familial adenomatous polyposis.
authors.forename: Holly
authors.initials: H
authors.lastname: Baker
mesh_terms: D011125:Adenomatous Polyposis Coli / Q000188:drug therapy* / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride / Q000627:therapeutic use*; D006801:Humans; D013467:Sulindac / Q000627:therapeutic use*
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D013467:Sulindac; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors